Provinces look to mix COVID-19 vaccines in light of changing supply
Pharmacist Barbara Violo shows off a vile of the Oxford-AstraZeneca COVID-19 vaccine after providing doses to customers at the Junction Chemist in Toronto on Friday, March 12, 2021. Ontario will likely mix and match COVID-19 vaccine doses in light of uncertain future supply of all the shots approved for use in Canada. THE CANADIAN PRESS/Nathan Denette May 10, 2021 - 2:30 PM
TORONTO - Ontario has become the latest province to signal it will likely mix COVID-19 vaccine brands as the country prepares for a flood of Pfizer and Moderna shots while some doctors questioned further use of Oxford-AstraZeneca.
Ontario likely to mix 1st and 2nd vaccine doses amid lack of AstraZeneca supply
Poll
yes
By The Canadian Press on May 10, 2021.
Pharmacist Barbara Violo shows off a vile of the Oxford-AstraZeneca COVID-19 vaccine after providing doses to customers at the Junction Chemist in Toronto on Friday, March 12, 2021. Ontario will likely mix and match COVID-19 vaccine doses in light of uncertain future supply of all the shots approved for use in Canada. THE CANADIAN PRESS/Nathan Denette
TORONTO – Ontario will likely mix and match COVID-19 vaccine doses in light of uncertain future supply of all the shots approved for use in Canada.
Ontario likely to mix 1st and 2nd vaccine doses amid lack of AstraZeneca supply
Poll
Independent
Pharmacist Barbara Violo shows off a vile of the Oxford-AstraZeneca COVID-19 vaccine after providing doses to customers at the Junction Chemist in Toronto on Friday, March 12, 2021. Ontario will likely mix and match COVID-19 vaccine doses in light of uncertain future supply of all the shots approved for use in Canada. THE CANADIAN PRESS/Nathan Denette
TORONTO – Ontario will likely mix and match COVID-19 vaccine doses in light of uncertain future supply of all the shots approved for use in Canada.
Health Minister Christine Elliott says it’s likely that recipients of the Oxford-AstraZeneca vaccine may receive a different shot for their second dose.
OTTAWA - With thousands of doses of Oxford-AstraZeneca vaccine creeping towards their expiration date in freezers across Canada, many provinces moved in mid-April to let people as young as 40 start getting vaccinated with them.
FREDERICTON - New Brunswick health officials on Wednesday reported the province's first death of someone who developed a blood clot after receiving the Oxford-AstraZeneca vaccine.